These included TUHR10TKB kidney cancer cell line sensitive to depletion of either of the PRC2 subunits (Table 3); the OC316 ovarian cancer line that was in the Top10 for EZH2 and EED (Table 3) and in the Top40 for SUZ12 (Supplementary File S1) and, finally, the VCAP prostate cancer line—in the Top10 for EZH2 and SUZ12 (Table 3) and in the Top40 for EED (Supplementary File S1). This evidence concerns the gene SUZ12 and prostate carcinoma.